Video
Microbiomepost conducted an exclusive interview with Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, about the effect of Bacillus subtilis DSM29784 secreted metabolites on poultry…
Microbiomepost conducted an exclusive interview with Jiri Snaidr, Founder and CEO at Vermicon AG, about the possibility to combine Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for advanced…
Microbiomepost conducted an exclusive interview with Eric Daliri, from Vilnius University, about the possibility of prevent diabetes modulating gut microbiome.
Microbiomepost conducted an exclusive interview with Nina Vinot, Bioprox Healthcare, about the new frontiers of the microbiome revolution: the role of soil microbiome in the agriculture space.
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
MicrobiomePost carried out a research analysis in collaboration with Analytics Arts to find out more about the motivations and frequency of probiotic consumption and the level of consumer information.
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
